CSTA and nasopharyngeal carcinoma: MIP-3α and cystatin A have been reported as novel biomarkers and prognosis predictors for NPC.9,10 The clinical significance of serum MIP-3α and cystatin A levels at different time points (pretreatment vs posttreatment) has not been fully explored.